Natural history of HLA expression during tumour development
- PMID: 8274189
- DOI: 10.1016/0167-5699(93)90264-L
Natural history of HLA expression during tumour development
Abstract
HLA expression is frequently altered in tumours compared to the tissue from which they originate. Given the central role of MHC products in the restriction of T-cell recognition, regulation of tumour HLA expression might be a strategy for the evasion of immune surveillance by the malignant cells. Federico Garrido, Peter Stern and colleagues present data from a variety of tumour types, suggesting that HLA class I alterations may occur at a particular step between the development of an in situ lesion and an invasive carcinoma.
Similar articles
-
Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?Semin Cancer Biol. 2007 Dec;17(6):459-68. doi: 10.1016/j.semcancer.2007.07.005. Epub 2007 Jul 31. Semin Cancer Biol. 2007. PMID: 17768067 Review.
-
The role of surface HLA-A,B,C molecules in tumour immunity.Cancer Surv. 1992;13:101-27. Cancer Surv. 1992. PMID: 1423320 Review.
-
Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.Int J Oncol. 2008 Mar;32(3):633-41. Int J Oncol. 2008. PMID: 18292941
-
The biological consequences of altered MHC class I expression in tumours.J Biol Regul Homeost Agents. 1999 Apr-Jun;13(2):90-6. J Biol Regul Homeost Agents. 1999. PMID: 10503731 Review.
-
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.Immunol Today. 1997 Feb;18(2):89-95. doi: 10.1016/s0167-5699(96)10075-x. Immunol Today. 1997. PMID: 9057360 Review.
Cited by
-
Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients.Int J Mol Sci. 2020 Oct 2;21(19):7295. doi: 10.3390/ijms21197295. Int J Mol Sci. 2020. PMID: 33023239 Free PMC article. Review.
-
The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors--lessons from normal and immunodeficient mice.Med Oncol. 1999 Dec;16(4):223-38. doi: 10.1007/BF02785868. Med Oncol. 1999. PMID: 10618685 Review.
-
A novel cell line and xenograft model of ampulla of Vater adenocarcinoma.Virchows Arch. 2004 Mar;444(3):269-77. doi: 10.1007/s00428-003-0936-6. Epub 2003 Dec 16. Virchows Arch. 2004. PMID: 14677066
-
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts.J Vis Exp. 2019 Jun 13;(148):10.3791/57011. doi: 10.3791/57011. J Vis Exp. 2019. PMID: 31259909 Free PMC article.
-
Clinical implication of HLA class I expression in breast cancer.BMC Cancer. 2011 Oct 20;11:454. doi: 10.1186/1471-2407-11-454. BMC Cancer. 2011. PMID: 22014037 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials